Javier Santos

18PUBLICATIONS
130CO-AUTHORS
Immunogenetics (incl. genetic immunology)Disease surveillanceFood properties (incl. characteristics and health benefits)Traditional Chinese medicine and treatmentsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Nov 03, 2026
Intestinal Permeability in Irritable Bowel Syndrome With and Without Comorbid Conditions: Results From the European DISCOvERIE Cohort.

|Aug 18, 2026
Rome V global epidemiology and validation survey: prevalence of disorders of gut-brain interaction and comparison with the Rome IV global epidemiology study.

|Nov 14, 2025
Efficacy and Safety of Gelatin Tannate and Tyndallized Acid Lactic Bacteria in Adults With Chronic Diarrhea and Altered Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled Study.

Javier Santos, Alina Iordache, Mihai Manolache

|Jul 20, 2025
Effect of STW 5-II (Iberogast-N) on Tolerance to Gastric Gas in Patients With Functional Dyspepsia. The IBO-2 Study.

Ariadna Aguilar, Luis Alcala-Gonzalez, Claudia Barber

|May 16, 2025
Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome.

Keren Hod, Giovanni Marasco, Luigi Colecchia

|Nov 26, 2024
A Phase II, Multicentric, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhea-Predominant Irritable Bowel Syndrome.

Lukas Michaja Balsiger, Javier Santos, Jordi Serra

Pageof 3

Frequent Collaborators

6 joint publications

Jan Tack

5 joint publications

Ami D Sperber

4 joint publications

Carmen Alonso-Cotoner

4 joint publications

Beatriz Lobo